Medifast provided earnings guidance for the first quarter of 2024. For the period, the company expects revenue to be in the range of $155 million to $175 million and diluted EPS to be in the range of $0.25 to $0.95.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.74 USD | -1.38% | +12.75% | -61.71% |
Apr. 30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
Apr. 30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.71% | 275M | |
+11.85% | 8.05B | |
+5.29% | 7.59B | |
+2.63% | 6.07B | |
-2.80% | 3.85B | |
-11.22% | 3.55B | |
-7.04% | 1.28B | |
-32.50% | 1.03B | |
+12.52% | 971M | |
-11.19% | 907M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast Provides Earnings Guidance for the First Quarter of 2024